Literature DB >> 15533449

The structural transition of the prion protein into its pathogenic conformation is induced by unmasking hydrophobic sites.

K-W Leffers1, J Schell, K Jansen, R Lucassen, T Kaimann, L Nagel-Steger, J Tatzelt, D Riesner.   

Abstract

A series of structural intermediates in the putative pathway from the cellular prion protein PrP(C) to the pathogenic form PrP(Sc) was established by systematic variation of low concentrations (<0.1%) of the detergent sodium dodecyl sulfate (SDS) or by the interaction with the bacterial chaperonin GroEL. Most extended studies were carried out with recombinant PrP (90-231) corresponding to the amino acid sequence of hamster prions PrP 27-30. Similar results were obtained with full-length recombinant PrP, hamster PrP 27-30 and PrP(C) isolated from transgenic, non-infected CHO cells. Varying the incubation conditions, i.e. the concentration of SDS, the GroEL and GroEL/ES, but always at neutral pH and room temperature, different conformations could be established. The conformations were characterized with respect to secondary structure as determined by CD spectroscopy and to molecular mass, as determined by fluorescence correlation spectroscopy and analytical ultracentrifugation: alpha-helical monomers, soluble alpha-helical dimers, soluble but beta-structured oligomers of a minimal size of 12-14 PrP molecules, and insoluble multimers were observed. A high activation barrier was found between the alpha-helical dimers and beta-structured oligomers. The numbers of SDS-molecules bound to PrP in different conformations were determined: Partially denatured, alpha-helical monomers bind 31 SDS molecules per PrP molecule, alpha-helical dimers 21, beta-structured oligomers 19-20, and beta-structured multimers show very strong binding of five SDS molecules per PrP molecule. Binding of only five molecules of SDS per molecule of PrP leads to fast formation of beta-structures followed by irreversible aggregation. It is discussed that strongest binding of SDS has an effect identical with or similar to the interaction with GroEL thereby inducing identical or very similar transitions. The interaction with GroEL/ES stabilizes the soluble, alpha-helical conformation. The structure and their stabilities and particularly the induction of transitions by interaction of hydrophobic sites of PrP are discussed in respect to their biological relevance.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15533449     DOI: 10.1016/j.jmb.2004.09.071

Source DB:  PubMed          Journal:  J Mol Biol        ISSN: 0022-2836            Impact factor:   5.469


  6 in total

1.  Mechanisms of prion protein assembly into amyloid.

Authors:  Jan Stöhr; Nicole Weinmann; Holger Wille; Tina Kaimann; Luitgard Nagel-Steger; Eva Birkmann; Giannantonio Panza; Stanley B Prusiner; Manfred Eigen; Detlev Riesner
Journal:  Proc Natl Acad Sci U S A       Date:  2008-02-11       Impact factor: 11.205

2.  Structure of prion β-oligomers as determined by short-distance crosslinking constraint-guided discrete molecular dynamics simulations.

Authors:  Jason J Serpa; Konstantin I Popov; Evgeniy V Petrotchenko; Nikolay V Dokholyan; Christoph H Borchers
Journal:  Proteomics       Date:  2021-09-16       Impact factor: 5.393

Review 3.  Prion infection: seeded fibrillization or more?

Authors:  Eva Birkmann; Detlev Riesner
Journal:  Prion       Date:  2008-04-23       Impact factor: 3.931

Review 4.  Aptamers Selected for Recognizing Amyloid β-Protein-A Case for Cautious Optimism.

Authors:  Farid Rahimi
Journal:  Int J Mol Sci       Date:  2018-02-27       Impact factor: 5.923

Review 5.  Role of prion protein aggregation in neurotoxicity.

Authors:  Alessandro Corsaro; Stefano Thellung; Valentina Villa; Mario Nizzari; Tullio Florio
Journal:  Int J Mol Sci       Date:  2012-07-11       Impact factor: 6.208

6.  Progress towards structural understanding of infectious sheep PrP-amyloid.

Authors:  Henrik Müller; Oleksandr Brener; Olivier Andreoletti; Timo Piechatzek; Dieter Willbold; Giuseppe Legname; Henrike Heise
Journal:  Prion       Date:  2014       Impact factor: 3.931

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.